A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan

Area of Science:

• Pharmacology
• Cell Biology
• Mathematical Modeling

Background:

• Understanding how anti-cancer drugs affect cell division is crucial for developing effective cancer therapies.
• Existing models often treat drug kinetics and cell cycle responses separately, limiting insights into drug-induced perturbations.

Purpose of the Study:

• To develop and validate a novel, integrated mathematical model for human cell growth in response to topotecan (TPT).
• To illustrate the mechanism by which TPT perturbs the cell cycle by coupling drug kinetics with cellular responses.

Main Methods:

• Developed a coupled mathematical model integrating TPT pharmacokinetics and cell cycle kinetics.
• Utilized in vitro experimental data of single-cell descriptors (molecular and behavioral events) for model validation.
• Compared model predictions against experimental data across a range of TPT concentrations.

Main Results:

• The integrated model successfully captured the complex interplay between TPT and the cell cycle.
• Demonstrated good qualitative agreement between model predictions and experimental in vitro cell cycle response data.
• The model effectively illustrates how TPT dose levels influence cell cycle perturbations.

Conclusions:

• The novel coupled model provides a unified framework for studying drug effects on cell cycle dynamics.
• This approach enhances our understanding of topotecan's mechanism of action at the single-cell level.
• The validated model can serve as a predictive tool for anti-cancer drug efficacy and cellular response.